{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:39:40Z","timestamp":1788907180523,"version":"build-2803163510"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.rec.2022.10.004","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T10:18:35Z","timestamp":1666606715000},"page":"384-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine"],"prefix":"10.1016","volume":"76","author":[{"given":"Alexandra","family":"Pons-Riverola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Ma\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Claver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oona","family":"Mero\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Com\u00edn-Colet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Anguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2022.10.004_bib0035","unstructured":"Our World in Data. Coronavirus (COVID \u2013 19) Vaccinations. Available at: https:\/\/ourworldindata.org\/covid-vaccinations?country=ESP. Accessed: 11 Aug 2021."},{"key":"10.1016\/j.rec.2022.10.004_bib0040","unstructured":"Pfizer-biontech covid-19 vaccine (bnt162, pf-07302048) vaccines and related biological products advisory committee briefing document. Meeting date: 10 December 2020. Available at: https:\/\/www.fda.gov\/media\/144246\/download Accessed 11 Aug 2021."},{"key":"10.1016\/j.rec.2022.10.004_bib0045","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41591-021-01630-0","article-title":"Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection","volume":"28","author":"Patone","year":"2022","journal-title":"Nat Med."},{"key":"10.1016\/j.rec.2022.10.004_bib0050","unstructured":"World Health Organization. COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS): updated guidance regarding myocarditis and pericarditis reported with COVID-19 mRNA vaccines. 2021. Available at: https:\/\/www.who.int\/news\/item\/09-07-2021-gacvs-guidance-myocarditis-pericarditis-covid-19-mrna-vaccines Accessed 11 Aug 2021."},{"key":"10.1016\/j.rec.2022.10.004_bib0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11886-019-1158-0","article-title":"Assessment of Myocarditis: Cardiac MR, PET\/CT, or PET\/MR?","volume":"21","author":"Chen","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.rec.2022.10.004_bib0060","doi-asserted-by":"crossref","first-page":"e05797","DOI":"10.1002\/ccr3.5797","article-title":"The first report of 2:1 atrioventricular block following COVID-19 vaccination","volume":"10","author":"Nasab","year":"2022","journal-title":"Clin Case Rep."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585722002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585722002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:02:03Z","timestamp":1761822123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585722002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1885585722002742"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2022.10.004","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Third-degree atrioventricular block associated with the SARS-CoV-2 mRNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2022.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2022.10.006","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}